Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Pharmacy chain CVS reported a strong fourth quarter, but lowered the bottom range for its 2022 outlook for cash flow.

CVS Stock Is Tumbling. Lowered Range for Cash-Flow Guidance Unnerved Investors.

CVS Health Corporation (CVS) CEO Karen Lynch on Q4 2021 Results - Earnings Call Transcript

After a year of unprecedented COVID-19-related gains, the nation's largest pharmacy chain is looking to leverage the new customer connections it made during the pandemic and prepare for a time without the benefit of vaccine and testing foot traffic and revenue.

CVS Sees $3B Tech Investment as COVID-19 Vaccine and Testing Set to Plunge

CVS Health Corp said on Wednesday it expects to administer 70% to 80% fewer COVID-19 vaccines in 2022 compared with last year, adding that in-store diagnostic testing could fall 40% to 50%.

CVS expects 70%-80% drop in COVID vaccine administration in 2022

The pharmacy chain offered guidance that appeared to disappoint.

CVS Earnings Top Estimates, But Guidance Disappoints

CVS reported more than $1 billion in quarterly profits thanks to a rush of customers being vaccinated against Covid-19 or tested for the virus as the Omicron variant surged.

Covid Vaccines And Testing Boost CVS Health Profits

CVS Earnings Topped Expectations. Its Stock Is Dropping.

CVS Health Corporation's CVS Q4 sales increased 10.1% Y/Y to $76.60 billion, beating the consensus of $75.55 billion. Get the Inside Access Traders Are Using to Profit More and Win Bigger.

CVS Health Fourth Quarter Performance Gets A Boost From COVID-19 Vaccinations, Reaffirms FY22 Outlook

(Reuters) -CVS Health Corp's quarterly profit rose 34.2% on Wednesday, helped by Omicron-spurred demand for COVID-19 tests and vaccinations.

CVS Health profit rises 34% on vaccine, test boost

CVS Health said demand for at-home Covid tests and booster shots lifted overall store sales, helping the company top expectations for fourth-quarter earnings.

CVS fourth-quarter earnings top expectations as Covid tests lift overall store sales

Shares of CVS Health Corp. CVS, +1.30% dropped 2.6% in premarket trading Wednesday, after the health services and drugstore operator reported fourth-quarter results that beat expectations but provided a mixed full-year outlook. Net income rose to $1.31 billion, or 98 cents a share, from $973 million, or 74 cents a share, in the year-ago period.

CVS Health stock pulls back after profit and revenue beat expectations but full-year outlook was mixed

WOONSOCKET, R.I., Feb. 9, 2022 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months and year ended December 31, 2021.

CVS HEALTH REPORTS STRONG FOURTH QUARTER AND FULL-YEAR 2021 RESULTS, CONFIRMS 2022 FULL-YEAR EPS GUIDANCE

CVS Health Corp (NYSE: CVS) popped up more than 1% higher on Tuesday, which put the stock into blue skies. The stock has run over 11% higher since reaching a low of $99.69 on Jan. 24.

How CVS Health's Stock Looks Heading Into Q4 Earnings Print

Cameco

Canopy Growth

Merger Monday was living up to its name, as Frontier Airlines has announced a merger with Spirit Airlines aimed at creating the lowest-cost U.S.

Earnings Previews: Cameco, Canopy Growth, CVS Health

PALO ALTO, Calif.--(BUSINESS WIRE)-- #access--Medable and CVS Health announced a collaboration to expand clinical trial access via select MinuteClinic™ locations using Medable's software platform.

Medable and CVS Health Announce Collaboration to Expand Clinical Trial Access

Alignment Healthcare

Anthem

Intuitive Surgical

Could health care stocks be back in focus amid market volatility?

Top 4 Health Care Stocks To Watch In February 2022

Dollar Tree

Lowe's

Generac Holdings

Mastercard

Robert Olstein (Trades, Portfolio), chairman and chief investment officer of Olstein Capital Management, disclosed this week that his firm's top five trades during the fourth quarter of 2021 included the closure of its position in Lowe's Companies Inc. ( LOW , Financial), the reduction of its holdings in Dollar Tree Inc. ( DLTR , Financial) and CVS Health Corp. ( CVS , Financial) and boosts to its stakes in Generac Holdings Inc. ( GNRC , Financial) and Mastercard Inc. ( MA , Financial).

Robert Olstein Axes Lowe's, Chops Dollar Tree Stake

CVS removes COVID-19 test purchasing limits

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVS Health (CVS) Reports Next Week: Wall Street Expects Earnings Growth

CVS Health (CVS) is expected to have seen a significant part of its specialty orders being placed digitally through Q4 months, with growth drivers being COVID testing, vaccines and omni-channel.

CVS Health (CVS) Q4 Earnings to Gain From COVID Vaccine Sales

Archer-Daniels-Midland Company

Danaos

Looking at the list of new highs this week, you could find at least 3 New York Stock Exchange-traded equities that couldn't stop going up.

These 3 Stocks Hit Higher Highs As The Market Tanked

Strength across the retail segment and growing specialty pharmacy revenues are driving CVS Health's (CVS) top line.

CVS Health (CVS) Hits a 52-Week High: What's Driving It?

CVS is undervalued based on current S&P ratios. CVS has plenty of growth ahead.

CVS: Growing With Larger Healthcare Market And Telehealth

CVS Health (CVS) closed the most recent trading day at $106.79, moving +1.84% from the previous trading session.

CVS Health (CVS) Gains As Market Dips: What You Should Know

AbbVie

Merck

Not only is the price right for these three healthcare stocks, but they all offer revenue growth along with an above-average dividend.

News for CVS Health Stock (CVS)